Also, we discovered the expression of SOX9 in in vivo tumours was not affected by PXN‐AS1 inhibition (Figure S1B), suggesting SOX9 was the upstream of PXN‐AS1 in GBM. This evidence concerns the gene SOX9 and neoplasm.